Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer (AVAXEL)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
ClinicalTrials.gov Identifier:
NCT01043484
First received: December 30, 2009
Last updated: March 23, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2016
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
No publications provided by Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):